View all news

Protein levels could predict if bowel cancer patients will benefit from Avastin

23 October 2012

Comparing levels of specific proteins that the drug Avastin targets could identify patients with advanced bowel cancer who will benefit from the treatment, according to research published in Clinical Cancer Research today (Tuesday 23 October).

Comparing levels of specific proteins that the drug Avastin targets could identify patients with advanced bowel cancer who will benefit from the treatment, according to research published in Clinical Cancer Research today (Tuesday 23 October).

Read the full press release on the University's news website

Edit this page